Evidence map›Paper›PMID 26624523›Full record

ArticleJournal of psychiatry & neuroscience : JPN2016

Facial emotion processing in patients with social anxiety disorder and Williams-Beuren syndrome: an fMRI study.

Cynthia Binelli, Armando Muñiz, Susana Subira, Ricard Navines, Laura Blanco-Hinojo, Debora Perez-Garcia, Jose Crippa, Magi Farré, Luis Pérez-Jurado, Jesus Pujol and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of psychiatry & neuroscience : JPN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Cognitive Neural Mechanism of Social Anxiety Disorder: A Meta-Analysis Based on fMRI Studies.International journal of environmental research and public health · 2021
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A cross-comparison of cognitive ability across 8 genomic disorders.Current opinion in genetics & development · 2021
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

Cynthia BinelliFrom the Department of Psychiatry and Psychology, Hospital Clínic, Institut d'Investigacions Biomèdicas August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM) G25, Barcelona, Spain (Binelli, Muñiz, Navinés, Martín-Santos); the Department of Clinical and Health Psychology. Universitat Autònoma de Barcelona, Bellaterra, Spain (Binelli, Subirà); the Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain (Muñiz, Martín-Santos); the MRI Research Unit, Hospital del Mar, CIBERSAM G21, Barcelona, Spain (Blanco-Hinojo, Pujol); the Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, SP, Brazil (Crippa); the Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme, IMIM-Hospital del Mar Medical Research Institute and Universitat Autònoma Barcelona, (UDIMAS-UAB), Barcelona, Spain (Pérez-García, Farré, Pérez-Jurado); and the Unitat de Genètica, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona (PRBB), and Centro de Investigación en Red en Enfermedades Raras (CIBERER), Barcelona, Spain (Pérez-Jurado).
Armando MuñizFrom the Department of Psychiatry and Psychology, Hospital Clínic, Institut d'Investigacions Biomèdicas August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM) G25, Barcelona, Spain (Binelli, Muñiz, Navinés, Martín-Santos); the Department of Clinical and Health Psychology. Universitat Autònoma de Barcelona, Bellaterra, Spain (Binelli, Subirà); the Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain (Muñiz, Martín-Santos); the MRI Research Unit, Hospital del Mar, CIBERSAM G21, Barcelona, Spain (Blanco-Hinojo, Pujol); the Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, SP, Brazil (Crippa); the Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme, IMIM-Hospital del Mar Medical Research Institute and Universitat Autònoma Barcelona, (UDIMAS-UAB), Barcelona, Spain (Pérez-García, Farré, Pérez-Jurado); and the Unitat de Genètica, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona (PRBB), and Centro de Investigación en Red en Enfermedades Raras (CIBERER), Barcelona, Spain (Pérez-Jurado).
Susana SubiraFrom the Department of Psychiatry and Psychology, Hospital Clínic, Institut d'Investigacions Biomèdicas August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM) G25, Barcelona, Spain (Binelli, Muñiz, Navinés, Martín-Santos); the Department of Clinical and Health Psychology. Universitat Autònoma de Barcelona, Bellaterra, Spain (Binelli, Subirà); the Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain (Muñiz, Martín-Santos); the MRI Research Unit, Hospital del Mar, CIBERSAM G21, Barcelona, Spain (Blanco-Hinojo, Pujol); the Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, SP, Brazil (Crippa); the Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme, IMIM-Hospital del Mar Medical Research Institute and Universitat Autònoma Barcelona, (UDIMAS-UAB), Barcelona, Spain (Pérez-García, Farré, Pérez-Jurado); and the Unitat de Genètica, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona (PRBB), and Centro de Investigación en Red en Enfermedades Raras (CIBERER), Barcelona, Spain (Pérez-Jurado).
Ricard NavinesFrom the Department of Psychiatry and Psychology, Hospital Clínic, Institut d'Investigacions Biomèdicas August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM) G25, Barcelona, Spain (Binelli, Muñiz, Navinés, Martín-Santos); the Department of Clinical and Health Psychology. Universitat Autònoma de Barcelona, Bellaterra, Spain (Binelli, Subirà); the Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain (Muñiz, Martín-Santos); the MRI Research Unit, Hospital del Mar, CIBERSAM G21, Barcelona, Spain (Blanco-Hinojo, Pujol); the Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, SP, Brazil (Crippa); the Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme, IMIM-Hospital del Mar Medical Research Institute and Universitat Autònoma Barcelona, (UDIMAS-UAB), Barcelona, Spain (Pérez-García, Farré, Pérez-Jurado); and the Unitat de Genètica, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona (PRBB), and Centro de Investigación en Red en Enfermedades Raras (CIBERER), Barcelona, Spain (Pérez-Jurado).
Laura Blanco-HinojoFrom the Department of Psychiatry and Psychology, Hospital Clínic, Institut d'Investigacions Biomèdicas August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM) G25, Barcelona, Spain (Binelli, Muñiz, Navinés, Martín-Santos); the Department of Clinical and Health Psychology. Universitat Autònoma de Barcelona, Bellaterra, Spain (Binelli, Subirà); the Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain (Muñiz, Martín-Santos); the MRI Research Unit, Hospital del Mar, CIBERSAM G21, Barcelona, Spain (Blanco-Hinojo, Pujol); the Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, SP, Brazil (Crippa); the Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme, IMIM-Hospital del Mar Medical Research Institute and Universitat Autònoma Barcelona, (UDIMAS-UAB), Barcelona, Spain (Pérez-García, Farré, Pérez-Jurado); and the Unitat de Genètica, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona (PRBB), and Centro de Investigación en Red en Enfermedades Raras (CIBERER), Barcelona, Spain (Pérez-Jurado).
Debora Perez-GarciaFrom the Department of Psychiatry and Psychology, Hospital Clínic, Institut d'Investigacions Biomèdicas August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM) G25, Barcelona, Spain (Binelli, Muñiz, Navinés, Martín-Santos); the Department of Clinical and Health Psychology. Universitat Autònoma de Barcelona, Bellaterra, Spain (Binelli, Subirà); the Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain (Muñiz, Martín-Santos); the MRI Research Unit, Hospital del Mar, CIBERSAM G21, Barcelona, Spain (Blanco-Hinojo, Pujol); the Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, SP, Brazil (Crippa); the Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme, IMIM-Hospital del Mar Medical Research Institute and Universitat Autònoma Barcelona, (UDIMAS-UAB), Barcelona, Spain (Pérez-García, Farré, Pérez-Jurado); and the Unitat de Genètica, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona (PRBB), and Centro de Investigación en Red en Enfermedades Raras (CIBERER), Barcelona, Spain (Pérez-Jurado).
Jose CrippaFrom the Department of Psychiatry and Psychology, Hospital Clínic, Institut d'Investigacions Biomèdicas August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM) G25, Barcelona, Spain (Binelli, Muñiz, Navinés, Martín-Santos); the Department of Clinical and Health Psychology. Universitat Autònoma de Barcelona, Bellaterra, Spain (Binelli, Subirà); the Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain (Muñiz, Martín-Santos); the MRI Research Unit, Hospital del Mar, CIBERSAM G21, Barcelona, Spain (Blanco-Hinojo, Pujol); the Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, SP, Brazil (Crippa); the Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme, IMIM-Hospital del Mar Medical Research Institute and Universitat Autònoma Barcelona, (UDIMAS-UAB), Barcelona, Spain (Pérez-García, Farré, Pérez-Jurado); and the Unitat de Genètica, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona (PRBB), and Centro de Investigación en Red en Enfermedades Raras (CIBERER), Barcelona, Spain (Pérez-Jurado).
Magi FarréFrom the Department of Psychiatry and Psychology, Hospital Clínic, Institut d'Investigacions Biomèdicas August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM) G25, Barcelona, Spain (Binelli, Muñiz, Navinés, Martín-Santos); the Department of Clinical and Health Psychology. Universitat Autònoma de Barcelona, Bellaterra, Spain (Binelli, Subirà); the Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain (Muñiz, Martín-Santos); the MRI Research Unit, Hospital del Mar, CIBERSAM G21, Barcelona, Spain (Blanco-Hinojo, Pujol); the Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, SP, Brazil (Crippa); the Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme, IMIM-Hospital del Mar Medical Research Institute and Universitat Autònoma Barcelona, (UDIMAS-UAB), Barcelona, Spain (Pérez-García, Farré, Pérez-Jurado); and the Unitat de Genètica, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona (PRBB), and Centro de Investigación en Red en Enfermedades Raras (CIBERER), Barcelona, Spain (Pérez-Jurado).
Luis Pérez-JuradoFrom the Department of Psychiatry and Psychology, Hospital Clínic, Institut d'Investigacions Biomèdicas August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM) G25, Barcelona, Spain (Binelli, Muñiz, Navinés, Martín-Santos); the Department of Clinical and Health Psychology. Universitat Autònoma de Barcelona, Bellaterra, Spain (Binelli, Subirà); the Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain (Muñiz, Martín-Santos); the MRI Research Unit, Hospital del Mar, CIBERSAM G21, Barcelona, Spain (Blanco-Hinojo, Pujol); the Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, SP, Brazil (Crippa); the Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme, IMIM-Hospital del Mar Medical Research Institute and Universitat Autònoma Barcelona, (UDIMAS-UAB), Barcelona, Spain (Pérez-García, Farré, Pérez-Jurado); and the Unitat de Genètica, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona (PRBB), and Centro de Investigación en Red en Enfermedades Raras (CIBERER), Barcelona, Spain (Pérez-Jurado).
Jesus PujolFrom the Department of Psychiatry and Psychology, Hospital Clínic, Institut d'Investigacions Biomèdicas August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM) G25, Barcelona, Spain (Binelli, Muñiz, Navinés, Martín-Santos); the Department of Clinical and Health Psychology. Universitat Autònoma de Barcelona, Bellaterra, Spain (Binelli, Subirà); the Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain (Muñiz, Martín-Santos); the MRI Research Unit, Hospital del Mar, CIBERSAM G21, Barcelona, Spain (Blanco-Hinojo, Pujol); the Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, SP, Brazil (Crippa); the Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme, IMIM-Hospital del Mar Medical Research Institute and Universitat Autònoma Barcelona, (UDIMAS-UAB), Barcelona, Spain (Pérez-García, Farré, Pérez-Jurado); and the Unitat de Genètica, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona (PRBB), and Centro de Investigación en Red en Enfermedades Raras (CIBERER), Barcelona, Spain (Pérez-Jurado).
Rocio Martin-SantosFrom the Department of Psychiatry and Psychology, Hospital Clínic, Institut d'Investigacions Biomèdicas August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM) G25, Barcelona, Spain (Binelli, Muñiz, Navinés, Martín-Santos); the Department of Clinical and Health Psychology. Universitat Autònoma de Barcelona, Bellaterra, Spain (Binelli, Subirà); the Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain (Muñiz, Martín-Santos); the MRI Research Unit, Hospital del Mar, CIBERSAM G21, Barcelona, Spain (Blanco-Hinojo, Pujol); the Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, SP, Brazil (Crippa); the Human Pharmacology and Clinical Neurosciences Research Group, Neurosciences Research Programme, IMIM-Hospital del Mar Medical Research Institute and Universitat Autònoma Barcelona, (UDIMAS-UAB), Barcelona, Spain (Pérez-García, Farré, Pérez-Jurado); and the Unitat de Genètica, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona (PRBB), and Centro de Investigación en Red en Enfermedades Raras (CIBERER), Barcelona, Spain (Pérez-Jurado).
Barcelona Biomedical Research Park · ESCentre for Biomedical Network Research on Rare Diseases · ESUniversitat de Barcelona · ESCentro de Investigación Biomédica en Red · ESCentro de Investigación Biomédica en Red de Salud Mental · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESHospital del Mar Research Institute · ESMunicipal Institute for Medical Research · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSocial anxiety disorder (SAD) and Williams-Beuren syndrome (WBS) are 2 conditions with major differences in terms of genetics, development and cognitive profiles. Both conditions are associated with compromised abilities in overlapping areas, including social approach, processing of social emotional cues and gaze behaviour, and to some extent they are associated with opposite behaviours in these domains. We examined common and distinct patterns of brain activation during a facial emotion processing paradigm in patients with SAD and WBS.

methodsWe examined patients with SAD and WBS and healthy controls matched by age and laterality using functional MRI during the processing of happy, fearful and angry faces.

resultsWe included 20 patients with SAD and 20 with WBS as well as 20 matched controls in our study. Patients with SAD and WBS did not differ in the pattern of limbic activation. We observed differences in early visual areas of the face processing network in patients with WBS and differences in the cortical prefrontal regions involved in the top-down regulation of anxiety and in the fusiform gyrus for patients with SAD. Compared with those in the SAD and control groups, participants in the WBS group did not activate the right lateral inferior occipital cortex. In addition, compared with controls, patients with WBS hypoactivated the posterior primary visual cortex and showed significantly less deactivation in the right temporal operculum. Participants in the SAD group showed decreased prefrontal activation compared with those in the WBS and control groups. In addition, compared with controls, participants with SAD showed decreased fusiform activation. Participants with SAD and WBS also differed in the pattern of activation in the superior temporal gyrus, a region that has been linked to gaze processing. LIMITATIONS: The results observed in the WBS group are limited by the IQ of the WBS sample; however, the specificity of findings suggests that the pattern of brain activation observed for WBS is more likely to reflect a neurobiological substrate rather than intellectual impairment per se.

conclusionPatients with SAD and WBS showed common and specific patterns of brain activation. Our results highlight the role of cortical regions during facial emotion processing in individuals with SAD and WBS.

Indexed as

AdolescentAdultBrainBrain MappingEmotionsFacial RecognitionFemaleHumansMagnetic Resonance ImagingMaleNeuropsychological TestsPhobia, SocialWilliams SyndromeYoung Adult

Identifiers

PMID26624523
PMCPMC4853209
OpenAlexW2188045538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.